News
Alaska’s Biotech Sugar Daddy Is Showering Money on Startups
March 7, 2016/
With a $50 billion fund willing to sit on illiquid investments for years, Alaska sees patience as a competitive advantage in making long-term bets on the drug industry.
Doni Bloomfield



